Zobrazeno 1 - 10
of 24
pro vyhledávání: '"V É, Sagynbaeva"'
Publikováno v:
Терапевтический архив, Vol 86, Iss 2, Pp 39-43 (2014)
AIM: To define the value of a new enzyme immunoassay in determining the level of anti-deamidated gliadin peptide (DGP) antibodies (Abs) in the diagnosis of celiac disease/MATERIAL AND METHODS: One hundred and twenty-four patients treated at the Depar
Externí odkaz:
https://doaj.org/article/0379233243404424a2a2991524cd0637
Autor:
A I Parfenov, O N Boldyreva, I N Ruchkina, O V Kniazev, V É Sagynbaeva, P L Shcherbakov, S G Khomeriki, L B Lazebnik, A G Konopliannikov
Publikováno v:
Терапевтический архив, Vol 86, Iss 2, Pp 32-38 (2014)
AIM: To define the value of adhesion molecules (sVCAM-1 integrin, P-selectin, E-selectin, and L-selectin) for the prediction and evaluation of the efficiency of treatment in patients with ulcerative colitis (UC) and Crohn's disease/MATERIAL AND METHO
Externí odkaz:
https://doaj.org/article/4750231d7d85479dae179af19c34ea82
Publikováno v:
Терапевтический архив, Vol 85, Iss 12, Pp 55-59 (2013)
AIM: To study biological (cell and anticytokine) therapy-induced changes in the levels of proinflammatory cytokines in patients with inflammatory bowel diseases (IBD)/MATERIAL AND METHODS: Forty-four patients with chronic continuous or chronic recurr
Externí odkaz:
https://doaj.org/article/d7dbdaf2ac264becbe16a2dd2173cb4b
Autor:
O V Kniazev, A I Parfenov, I N Ruchkina, A G Konopliannikov, V N Drozdov, V É Sagynbaeva, T I Ivkina
Publikováno v:
Терапевтический архив, Vol 85, Iss 2, Pp 57-60 (2013)
A search for ways to overcome the secondary inefficiency of anti-cytokine therapy (ACT) with infliximab (IFX) in patients with inflammatory bowel diseases (IBD) remains relevant and determines the need for new approaches to solving this problem. The
Externí odkaz:
https://doaj.org/article/ae2d35737f724dc18e35478175aabd96
Autor:
V É, Sagynbaeva
Publikováno v:
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (12)
There were found that patients with ulcerative colitis (UC) in the presence of two types of autoantibodies to antigens of neutrophils is observed in less pronounced activity in the course of the disease compared with those patients with a spectrum of
Publikováno v:
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (8)
The complex determination of serum autoantibodies to hepatic antigens using enzyme immunoassay and immunoblot allows to increase the frequency of overlap syndrome identification during autoimmune hepatic disorders and its early diagnostics, that has
Autor:
V É, Sagynbaeva, L B, Lazebnik
Publikováno v:
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (7)
The increase in the concentration level of calprotectin in serum (ICP) in patients with inflammatory bowel disease (IBD) is closely associated with increased rates of acute phase of inflammation and combined with worsening of clinical and endoscopic
Autor:
V É, Sagynbaeva, L B, Lazebnik
Publikováno v:
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (7)
During ulcerative colitis in the exacerbation phase the high level of circulating immune complexes -C1q and -C3d (CIC-C1q and -C3d) was detected in 35.4% and 28.9% of patients respectively. This raise of CIC-C1q and -C3d level was accompanied by incr
Publikováno v:
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (8)
Among 106 patients with autoimmune liver disease in 12 (11.3%) were found autoantibodies to asialoglycoprotein receptor (anti-ASGPR): in 5 (9.1%) of 55 with PBC, and 4 (17.4%) of 23 with AIH and 3 (10.7%) of 28 patients with syndrome chiasm (PBC + AI
Publikováno v:
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (11)
The article presents the data on the assessment of nutritional status, taking into account humoral immunologic criteria of patients with ulcerative colitis.